Cian Healthcare
Cian Healthcare (CHCL) share price was ₹31.57 at the 27 Oct 2026 close; sector Healthcare. The share price rose 380.5% over the year to 27 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹17 Cr, against ₹12 Cr a year earlier and net profit was −₹18 Cr, against −₹8 Cr a year earlier (compared with Mar 2025). Promoters held 95.00% of Cian Healthcare in Mar 2026, up 67.89 percentage points from Sep 2025.
Peer Comparison
Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
| ₹1,765.80 | 35.03 | 4,23,675 Cr | 5.07 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,653.00 | 87.61 | 2,56,257 Cr | 15.29 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,606.60 | 72.32 | 1,75,220 Cr | 9.54 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,186.60 | 108.03 | 1,18,145 Cr | 22.29 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,181.30 | 26.29 | 1,17,835 Cr | 4.35 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,338.80 | 34.67 | 1,11,747 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,364.70 | 32.70 | 1,10,248 Cr | 3.11 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
| Cian Healthcare (this company) | — | — | — | — | — | — | — | 95 Cr | -21 Cr |
| Median 8 companies | ₹1,765.80 | 35.03 | 1,18,145 Cr | 5.07 | 0.61% | 13.79% | 17.94% | 22,787 Cr | 3,055 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
2- Company has reduced debt.
- Promoter holding has increased by 67.9% over last quarter.
Weaknesses
6- Stock is trading at 8.21 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -17.4% over past five years.
- Company has a low return on equity of -18.6% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 163 days.
Technical Indicators
Oscillators
Bearish
Overall
Bullish
Moving Averages
Bullish
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29 | 28 | 39 | 35 | 47 | 31 | 38 | 31 | 33 | 62 | 19 | 12 | 17 |
| Expenses | 26 | 23 | 34 | 28 | 44 | 30 | 32 | 24 | 28 | 51 | 20 | 17 | 20 |
| Operating Profit | 3 | 4 | 5 | 7 | 3 | 1 | 5 | 7 | 4 | 11 | -1 | -5 | -3 |
| OPM % | 10% | 15% | 13% | 20% | 7% | 2.9% | 14% | 22% | 14% | 18% | -8% | -44% | -18% |
| Other Income | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | -12 | 0 | -13 |
| Interest | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 6 | 2 | 1 | 0 |
| Depreciation | 2 | 3 | 2 | 1 | 2 | 2 | 3 | 3 | 3 | 5 | 2 | 2 | 2 |
| PBT | -2 | -2 | -1 | 2 | -2 | -4 | 0 | 2 | -1 | 0 | -18 | -8 | -18 |
| Tax % | 0% | 17% | 23% | 28% | 7% | -13% | -167% | 14% | 37% | -400% | 0% | 0% | 0% |
| Net Profit | -2 | -2 | -1 | 1 | -2 | -4 | 0 | 2 | -1 | 0 | -18 | -8 | -18 |
| EPS (₹) | -0.86 | -0.75 | -0.46 | 0.48 | -0.72 | -1.54 | 0.19 | 0.62 | -0.59 | 0.1 | -7.3 | -3.09 | -7.19 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 57 | 74 | 78 | 69 | 62 | 31 | 28 |
| Expenses | 50 | 62 | 74 | 56 | 51 | 37 | 35 |
| Operating Profit | 7 | 12 | 4 | 13 | 11 | -7 | -7 |
| OPM % | 13% | 16% | 6% | 19% | 18% | -21% | -23% |
| Other Income | 1 | 0 | 0 | 1 | 0 | -12 | -12 |
| Interest | 7 | 8 | 7 | 6 | 6 | 3 | 1 |
| Depreciation | 4 | 3 | 4 | 5 | 5 | 4 | 4 |
| PBT | -4 | 1 | -6 | 2 | 0 | -26 | -23 |
| Tax % | 7% | 91% | -8% | -2% | -1600% | 0% | 0% |
| Net Profit | -4 | 0 | -6 | 2 | 1 | -26 | -23 |
| EPS (₹) | -1.62 | 0.02 | -2.21 | 0.81 | 0.34 | -10.39 | -9.32 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 23 | 23 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 35 | 35 | 30 | 32 | 33 | 7 | -16 |
| Borrowings | 73 | 71 | 63 | 61 | 56 | 55 | 29 |
| Other Liabilities | 25 | 28 | 47 | 42 | 47 | 69 | 24 |
| Total Liabilities | 157 | 157 | 166 | 160 | 161 | 156 | 62 |
| Fixed Assets | 39 | 37 | 50 | 45 | 39 | 35 | 32 |
| CWIP | 25 | 26 | 13 | 14 | 15 | 15 | 6 |
| Investments | 5 | 5 | 5 | 5 | 5 | 5 | 0 |
| Other Assets | 87 | 90 | 98 | 97 | 102 | 101 | 23 |
| Total Assets | 157 | 157 | 166 | 160 | 161 | 156 | 62 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | -7 | 6 | 9 | 5 | 12 | 21 | -1 |
| Investing | -27 | 3 | 1 | 3 | -1 | 0 | 13 |
| Financing | 36 | -10 | -11 | -7 | -10 | -4 | -28 |
| Net Cash Flow | 1 | -1 | -1 | 0 | 0 | 17 | -17 |
| Free Cash Flow | -26 | 4 | 4 | 4 | 11 | 20 | 7 |
| CFO/EBITDA | -99 | 49 | 197 | 37 | 106 | -315 | 22 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 128 | 94 | 125 | 140 | 121 | 206 | 163 |
| Inventory Days | 214 | 277 | 300 | 400 | 486 | 420 | 82 |
| Days Payable | 176 | 186 | 270 | 296 | 371 | 671 | 219 |
| Cash Conversion Cycle | 166 | 185 | 155 | 244 | 236 | -45 | 26 |
| Working Capital Days | 15 | 16 | 38 | 41 | 26 | -729 | -96 |
| ROCE % | — | 7% | 0% | 7% | 5% | -11% | -15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Cian Healthcare insights
62 extracted metrics + investor summaries across FY16–FY26.
Documents
Frequently Asked Questions about Cian Healthcare
What does Cian Healthcare Ltd do?
Where is Cian Healthcare Ltd (CHCL) listed?
Which sector does Cian Healthcare Ltd belong to?
What is the 52-week high and low of Cian Healthcare Ltd?
Company Information
Cian Healthcare Ltd is a BSE-SME listed pharmaceutical-formulations manufacturer with own /franchise brands, third-party manufacturing, institutional/government supply and exports. It makes tablets, capsules, soft-gels, liquid orals, ointments/creams, sachets and cosmetics across gynaecology, haematinic, cardio-diabetic, orthopaedic, paediatric, derma-cosmetic, antibiotic, CNS, vitamins and nutrients. The company exited CIRP under new promoter control in FY26[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/542678.md for Cian Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.